Maternal Smoking and Metabolic Health Biomarkers in Newborns.

Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses...

Full description

Bibliographic Details
Main Authors: Fang Fang, Zhong-Cheng Luo, Anissa Dejemli, Edgard Delvin, Jun Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4658089?pdf=render
id doaj-c0b086b9ce67406b8f8ad11cddef70bd
record_format Article
spelling doaj-c0b086b9ce67406b8f8ad11cddef70bd2020-11-25T01:51:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014366010.1371/journal.pone.0143660Maternal Smoking and Metabolic Health Biomarkers in Newborns.Fang FangZhong-Cheng LuoAnissa DejemliEdgard DelvinJun ZhangMaternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns.In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of β-cell function).Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and non-smoking mothers.Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal β-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring.http://europepmc.org/articles/PMC4658089?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Fang Fang
Zhong-Cheng Luo
Anissa Dejemli
Edgard Delvin
Jun Zhang
spellingShingle Fang Fang
Zhong-Cheng Luo
Anissa Dejemli
Edgard Delvin
Jun Zhang
Maternal Smoking and Metabolic Health Biomarkers in Newborns.
PLoS ONE
author_facet Fang Fang
Zhong-Cheng Luo
Anissa Dejemli
Edgard Delvin
Jun Zhang
author_sort Fang Fang
title Maternal Smoking and Metabolic Health Biomarkers in Newborns.
title_short Maternal Smoking and Metabolic Health Biomarkers in Newborns.
title_full Maternal Smoking and Metabolic Health Biomarkers in Newborns.
title_fullStr Maternal Smoking and Metabolic Health Biomarkers in Newborns.
title_full_unstemmed Maternal Smoking and Metabolic Health Biomarkers in Newborns.
title_sort maternal smoking and metabolic health biomarkers in newborns.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns.In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of β-cell function).Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and non-smoking mothers.Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal β-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring.
url http://europepmc.org/articles/PMC4658089?pdf=render
work_keys_str_mv AT fangfang maternalsmokingandmetabolichealthbiomarkersinnewborns
AT zhongchengluo maternalsmokingandmetabolichealthbiomarkersinnewborns
AT anissadejemli maternalsmokingandmetabolichealthbiomarkersinnewborns
AT edgarddelvin maternalsmokingandmetabolichealthbiomarkersinnewborns
AT junzhang maternalsmokingandmetabolichealthbiomarkersinnewborns
_version_ 1724997874093129728